WebMar 7, 2024 · NEWARK, Calif., March 7, 2024 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ... our ability to use and expand our programs to build a pipeline of product candidates, ... WebApr 11, 2024 · Tyvärr är jag inte så konsekvent att pris är den enda intressanta variabeln, pipeline är också en viktig faktor, och det förklarar att bolagen har lite olika profil. De är alla just nu helt OK prissatta, och en jämnt viktat portfölj skulle kunna gå bra.
Protagonist Therapeutics: Robust Polycythemia Vera Data Is Just …
WebMar 9, 2024 · Pipeline and regulatory updates from Protagonist (PTGX) and BioMarin (BMRN) are the key highlights from the biotech sector during the past week. WebIts product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, ... PTGX will report Q4 2024 earnings on 05/10/2024. Quarterly Actuals. the phoenix at lake lanier
PTGX Stock Forecast, Price & News (Protagonist …
WebApr 8, 2024 · Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA. See Also. Get a free copy of the StockNews.com research report on Protagonist Therapeutics (PTGX) Costco Sales Disappoint, Markets Are Missing This Upside Driver WebWelcome to Protagonist, a clinical-stage biopharmaceutical company. We strive to improve patients’ lives through the power of peptide drug discovery and development, targeting … WebJun 10, 2024 · PTGX has a market capitalization of ~$590 million and cash on hand of ~$240 million. They have stated they have enough cash to fund pipeline programs through mid-2024. Their pipeline consists of ... the phoenix at savannah